603392.SH
万泰生物
SSE · Healthcare · Biotechnology · CN
CNY 28.09
−8.17%Forward multiples
Based on analyst estimates
- P/E forward
- 6.99x
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 15.45x
Trailing multiples
Trailing twelve months
- P/E TTM
- -89.18x
- PEG TTM
- —
- Price / book
- 3.03x
- Price / sales
- 18.02x
- Price / cash flow
- -621.23x
Enterprise value
- Enterprise value
- CNY 33.0B
- EV / sales
- 17.02x
- EV / EBITDA
- -251.49x
- EV / EBIT
- -70.00x
- Market cap
- CNY 35.5B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026